Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 10086068 was granted and assigned to Aimmune Therapeutics on October, 2018 by the United States Patent and Trademark Office. | 10086068 | October 2, 2018 | |||||||
Patent 10449118 was granted and assigned to Aimmune Therapeutics on October, 2019 by the United States Patent and Trademark Office. | 10449118 | October 22, 2019 | |||||||
Patent 10918676 was granted and assigned to Aimmune Therapeutics on February, 2021 by the United States Patent and Trademark Office. | 10918676 | February 16, 2021 | |||||||
Patent 9198869 was granted and assigned to Aimmune Therapeutics on December, 2015 by the United States Patent and Trademark Office. | 9198869 | December 1, 2015 | |||||||
Patent 10512686 was granted and assigned to Aimmune Therapeutics on December, 2019 by the United States Patent and Trademark Office. | 10512686 | December 24, 2019 | |||||||
Patent 9492535 was granted and assigned to Aimmune Therapeutics on November, 2016 by the United States Patent and Trademark Office. | 9492535 | November 15, 2016 | |||||||
Patent D866321 was granted and assigned to Aimmune Therapeutics on November, 2019 by the United States Patent and Trademark Office. | D866321 | November 12, 2019 | |||||||
Patent D866322 was granted and assigned to Aimmune Therapeutics on November, 2019 by the United States Patent and Trademark Office. | D866322 | November 12, 2019 | |||||||
Patent D866320 was granted and assigned to Aimmune Therapeutics on November, 2019 by the United States Patent and Trademark Office. | D866320 | November 12, 2019 | |||||||
Patent 10653773 was granted and assigned to Aimmune Therapeutics on May, 2020 by the United States Patent and Trademark Office. | 10653773 | May 19, 2020 |